News

Brixton Metals Showcases Promising Drilling Results at Trapper

Brixton Metals Showcases Promising Drilling Results at Trapper

Exciting Drilling Results at the Trapper Gold Target

VANCOUVER, British Columbia – Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) is thrilled to share noteworthy advancements from its drilling campaign at the Trapper Gold Target, located within its wholly owned Thorn Project. This project is located in a strategically promising region of Northwest British Columbia.

Highlighting Noteworthy Results

The recent drill results have been particularly impressive. For instance, Hole THN24-304 recorded a substantial span of 227.50m with an average of 0.50 g/t Au, commencing at a depth of 40.00m. Among the intercepts, several high-grade sections were observed, specifically:

High-Grade Gold Intercepts

1. A significant 82.00m portion grading 1.27 g/t Au
2. Additional intervals included 49.00m of 2.02 g/t Au
3. Plus, high-grade core intervals comprising 27.00m of 3.49 g/t Au, with a standout 2.00m tagged at 44.43 g/t Au. This encapsulates the exciting potential of the Trapper Gold Target.

Understanding the Geological Context

Gold mineralization at the Trapper site is notably linked to structural features along the Lawless Fault. Observations present a northwest-southeast trend with a moderate dip to the north, showcasing a variety of underlying geological formations. The nature of the gold here is associated with base metals, often found alongside galena, sphalerite, and controlled by the volcanic rock structures.

Potential for Future Discoveries

The comprehensive 2024 drill program has spanned 2,745.60m over a series of 11 HQ-sized diamond drill holes. Christina Anstey, Vice President of Exploration, expressed enthusiasm over these high-grade findings, remarking on the sizeable footprint of the mineralization zone, which stretches 600 meters wide across a wider 4km gold geochemical anomaly. This promising horizon holds potential for future exploration and expansion of the Trapper footprint.

Additionally Noteworthy Drilling Information

Even with the success recounted in Hole 304, the subsequent Hole 305 faced challenges and had to be abandoned after the drill rods became lodged. Nevertheless, the findings from Hole 304 significantly bolster the anticipated outcomes of this ongoing drilling campaign.

Future Drilling Plans

Future explorations will continue to focus on the existing gold-bearing zones at Trapper, aiming to expand the known areas of mineralization. The geological team is preparing to delve deeper, incorporating a combination of mapping and geophysics, along with further drilling assays.

About Brixton Metals Corporation

Brixton Metals is dedicated to advancing exploration initiatives across its projects, with a focus on uncovering valuable resources in accessible regions. With multiple projects under its belt, including the significant Thorn Project and additional properties in Montana and Ontario, Brixton aims for continued growth and discovery in the mining sector.

For inquiries or more information, please reach out to our Investor Relations representative. We welcome your interest!

Frequently Asked Questions

1. What are Brixton Metals' recent drilling results?

Recent drilling at the Trapper Gold Target yielded impressive results, notably including 8.00m of 11.37 g/t Au within a broader 227.50m segment of lower grades.

2. Where is the Trapper Gold Target located?

The Trapper Gold Target is located within the Thorn Project in Northwest British Columbia, which is entirely owned by Brixton Metals Corporation.

3. What did the geological analysis reveal?

The analysis indicates that gold mineralization is structurally controlled by the Lawless Fault, enhancing the potential for high-grade finds across its spans.

4. How has the 2024 drill program been structured?

The 2024 program consists of 2,745.60 meters drilled across 11 HQ-sized diamond drill holes designed to expand on previous findings.

5. Who should I contact for investor relations?

For investor inquiries, please contact Mr. Michael Rapsch, Senior Manager, Investor Relations, or call the company directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading